Polpharma acquires Biofarm for 257 million euros to enter Romanian pharmaceutical market

Polish pharmaceutical group Polpharma has completed the acquisition of Romanian manufacturer Biofarm for 257 million euros. This transaction marks Polpharma's entry into the Romanian market, with stated intentions to expand the local product portfolio.